LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
43 hedge funds and large institutions have $79.8M invested in LYRA THERAPEUTICS INC in 2020 Q2 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.09% more ownership
Funds ownership: 0% → 1.09% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$47.1M |
| 2 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
+$16.1M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.74M |
| 5 |
BlackRock
New York
|
+$3M |
Top Sellers
LYRA Hedge Fund Activity: Q2 2020 in Review
43 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q2 2020, worth a combined $79.8M.
Buyers outnumbered sellers: 43 funds opened new LYRA positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $47.1M.
- 43 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $79.8M of LYRA THERAPEUTICS INC stock for Q2 2020.
- 43 funds opened new LYRA THERAPEUTICS INC positions in Q2 2020 and 0 closed out, a net change of +43 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q2 2020 was Perceptive Advisors, an estimated $47.1M added.
Based on aggregated 13F filings for Q2 2020.